Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer
Clinical Pharmacokinetics · 2026-08 · 65 (8) · 1217-1228
DOI: 10.1007/s40262-026-01643-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 23.06.2026. Verfasst von Yan Ji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. yan.ji@novartis.com. Hauptthemen laut MEDLINE: Aminopyridines, Antineoplastic Agents, Breast Neoplasms, Purines. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novartis Pharmaceuticals Corporation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. yan.ji@novartis.com.
- Novartis Pharma AG, Basel, Switzerland.
- Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
- University Hospital Erlangen Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
- Interdisciplinary Breast Cancer Center, Helios Klinikum Berlin-Buch, Berlin, Germany.
- St. Vincent's University Hospital, Dublin, Ireland.
Förderung
- Novartis Pharmaceuticals Corporation
Zitieren
APA
Ji, Y., Wang, C., Combes, F. P., Ho, Y. Y., Fasching, P. A., Untch, M., Zarate, J. P., & Crown, J. (2026). Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer. Clinical Pharmacokinetics, 65(8), 1217-1228. https://doi.org/10.1007/s40262-026-01643-3
Vancouver
Ji Y, Wang C, Combes FP, Ho YY, Fasching PA, Untch M, et al. Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer. Clinical Pharmacokinetics. 2026;65(8):1217-1228. doi:10.1007/s40262-026-01643-3
BibTeX
@article{Ji2026,
author = {Ji, Yan and Wang, Craig and Combes, Francois Pierre and Ho, Yu-Yun and Fasching, Peter A and Untch, Michael and Zarate, Juan Pablo and Crown, John},
title = {Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer},
journal = {Clinical Pharmacokinetics},
year = {2026},
volume = {65},
number = {8},
pages = {1217--1228},
doi = {10.1007/s40262-026-01643-3}
}
EUVIMED